日本与北美MDA5阳性皮肌炎患者队列的B细胞表位谱比较揭示免疫库与肺死亡直接相关
该研究比较日本17例与北美24例MDA5阳性皮肌炎患者的B细胞表位谱与临床特征。日本患者以关节炎(47%)和间质性肺病(100%)高发,血清主要识别MDA5片段A、B、E,而北美患者主要识别片段H。日本患者抗片段A抗体水平与快速进展型间质性肺病显著相关(P<0.01),并与肺死亡相关。
要点
- 日本MDA5阳性皮肌炎患者关节炎占47%、间质性肺病占100%。
- 日本患者血清主要识别MDA5片段A、B、E,北美患者主要识别片段H。
- 日本患者抗片段A抗体水平与快速进展型间质性肺病相关(P<0.01),并与肺死亡相关。
核心结论
- 日本与北美MDA5阳性皮肌炎患者B细胞表位谱明显不同,且与日本患者快速进展型间质性肺病患病率更高和临床结局更差相关。
研究设计与样本
- 研究采用ELISA法检测日本17例MDA5阳性皮肌炎患者血清对155个重叠氨基酸MDA5亚片段的抗体识别,并与独立北美队列(n=24)的临床/血清学特征比较。
- 采用Brunner Munzel检验评估临床特征与标准化抗MDA5亚片段抗体滴度的关联,并用受试者工作特征(ROC)分析和Kaplan-Meier曲线评估抗MDA5片段抗体水平与特定临床特征/结局的关系。
主要发现
- 日本17例MDA5阳性皮肌炎患者中关节炎患病率为47%,间质性肺病患病率为100%。
- 日本患者血清主要识别MDA5片段A(氨基酸1-155)、B(氨基酸130-284)和E(氨基酸517-671),北美患者(n=24)血清主要识别片段H(氨基酸905-1026)。
- 日本患者抗片段A抗体水平与快速进展型间质性肺病显著相关(P<0.01)。
- 联合队列分析中,ROC和Kaplan-Meier曲线显示抗片段A抗体水平与快速进展型间质性肺病及肺死亡有强关联。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Anti-melanoma differentiation-associated gene 5 antibody-positive (MDA5+) DM patients exhibit clinical features that vary by geographical and ethnic/genetic distribution. The objective of this study was to investigate whether B cell epitope profiles and corresponding clinical features distinguished two independent cohorts of MDA5+ DM. METHODS: ELISA-based methods were used to determine the relationship between antibody recognition of 155 overlapping amino acid MDA5 subfragments and clinical features of 17 MDA5+ DM patients from Japan. Associations between clinical features and standardized anti-MDA5 subfragment antibody titres were assessed via Brunner Munzel testing and compared with the clinical/serological profiles of an independent North American cohort. Receiver operater characteristic (ROC) analyses and Kaplan-Meier curves were used to further assess the relationship between anti-MDA5 fragment antibody levels and specific clinical features/outcomes. RESULTS: Clinical characterization of a Japanese cohort of 17 MDA5+ DM patients revealed a high prevalence of arthritis (47%) and interstitial lung disease (ILD) (100%). Serological profiling demonstrated predominant antibody recognition of MDA5 fragments A (aa 1-155), B (aa 130-284) and E (aa 517-671) in a pattern that was distinct from North American MDA5+ patients (n = 24), whose sera preferentially recognized fragment H (aa 905-1026). Statistical analysis revealed a striking association between anti-fragment A antibody levels and rapidly progressive ILD (RP-ILD) among Japanese patients (P < 0.01). ROC and Kaplan-Meier curves also demonstrated a strong relationship between anti-fragment A antibody levels, RP-ILD, and pulmonary death in combined cohort analyses. CONCLUSIONS: Japanese and North American MDA5+ DM patients manifest markedly different B cell epitope profiles that are associated with higher prevalence of RP-ILD and worse clinical outcome among Japanese patients.
引用
- Yamaguchi K, Poland P, Zhu L, et al. Comparative B cell epitope profiling in Japanese and North American cohorts of MDA5+ dermatomyositis patients reveals a direct association between immune repertoire and pulmonary mortality. Rheumatology (Oxford). 2025. PMID: 39186037. doi:10.1093/rheumatology/keae466
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。